Literature DB >> 11412529

[Clinical guidelines for the diagnosis and treatment of chronic obstructive pulmonary disease].

J A Barberà1, G Peces-Barba, A G Agustí, J L Izquierdo, E Monsó, T Montemayor, J L Viejo.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11412529     DOI： 10.1016/s0300-2896(01)75074-0

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN： 0300-2896            Impact factor:   4.872


× No keyword cloud information.
  19 in total

Review 1.  COPD exacerbations.5: management.

Authors:  R Rodríguez-Roisin
Journal:  Thorax       Date:  2006-06       Impact factor: 9.139

2.  Inappropriate overuse of inhaled corticosteroids for COPD patients: impact on health costs and health status.

Authors:  Javier de Miguel-Díez; Pilar Carrasco-Garrido; Javier Rejas-Gutierrez; Antonio Martín-Centeno; Elena Gobartt-Vázquez; Valentín Hernandez-Barrera; Miguel Angel Gil de; Rodrigo Jimenez-Garcia
Journal:  Lung       Date:  2011-04-17       Impact factor: 2.584

3.  Clinical efficacy of anti-pneumococcal vaccination in patients with COPD.

Authors:  I Alfageme; R Vazquez; N Reyes; J Muñoz; A Fernández; M Hernandez; M Merino; J Perez; J Lima
Journal:  Thorax       Date:  2005-10-14       Impact factor: 9.139

4.  Evaluation of a combined strategy directed towards health-care professionals and patients with chronic obstructive pulmonary disease (COPD): information and health education feedback for improving clinical monitoring and quality-of-life.

Authors:  Carles Valero; Mònica Monteagudo; Maria Llagostera; Xavier Bayona; Sílvia Granollers; Mateo Acedo; Juan J Ferro; Lluïsa Rodríguez-Latre; Jesús Almeda; Laura Muñoz
Journal:  BMC Public Health       Date:  2009-12-01       Impact factor: 3.295

5.  Usefulness of inspiratory capacity measurement in COPD patients in the primary care setting.

Authors:  Antonio Madueño; Antonio Martín; Juan-Antonio Péculo; Esther Antón; Alejandra Paravisini; Antonio León
Journal:  Int J Gen Med       Date:  2009-12-29

6.  The influence of heart disease on characteristics, quality of life, use of health resources, and costs of COPD in primary care settings.

Authors:  Javier de Miguel-Díez; Pilar Carrasco-Garrido; Javier Rejas-Gutierrez; Antonio Martín-Centeno; Elena Gobartt-Vázquez; Valentín Hernandez-Barrera; Angel Gil de Miguel; Rodrigo Jimenez-Garcia
Journal:  BMC Cardiovasc Disord       Date:  2010-02-18       Impact factor: 2.298

7.  XRCC1 Arg194Trp polymorphism and risk of chronic obstructive pulmonary disease.

Authors:  Jungang Xie; Shifang Yang; Yongjian Xu; Zhenxiang Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-10-11

8.  Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease.

Authors:  Alicia Lacoma; Cristina Prat; Felipe Andreo; Luis Lores; Juan Ruiz-Manzano; Vicente Ausina; Jose Domínguez
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-02-28

9.  Is it possible to diagnose the therapeutic adherence of patients with COPD in clinical practice? A cohort study.

Authors:  Pilar Barnestein-Fonseca; José Leiva-Fernández; Francisca Vidal-España; Antonio García-Ruiz; Daniel Prados-Torres; Francisca Leiva-Fernández
Journal:  BMC Pulm Med       Date:  2011-01-24       Impact factor: 3.317

10.  Assessment of a primary and tertiary care integrated management model for chronic obstructive pulmonary disease.

Authors:  Ignasi Bolíbar; Vicente Plaza; Mariantònia Llauger; Ester Amado; Pedro A Antón; Ana Espinosa; Leandra Domínguez; Mar Fraga; Montserrat Freixas; Josep A de la Fuente; Iskra Liguerre; Casimira Medrano; Meritxell Peiro; Mariantònia Pou; Joaquin Sanchis; Ingrid Solanes; Carles Valero; Pepi Valverde
Journal:  BMC Public Health       Date:  2009-02-24       Impact factor: 3.295
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.